PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1994 November; 87(11): 704–706.
PMCID: PMC1294943

Surveillance of duodenal polyps in familial adenomatous polyposis: progress report.

Abstract

Familial adenomatous polyposis (FAP) is characterized by the presence of premalignant adenomas of the large and small bowel. Prophylactic colectomy deals with the risk for colon cancer, leaving duodenal cancer as the leading cause of death. Although most FAP patients have duodenal adenomas, only approximately 5% develop duodenal cancer. This study looks at progression of duodenal polyps with time. The outcome of endoscopic surveillance in the duodenum of 70 patients with familial adenomatous polyposis was determined. A mean of 40 months elapsed between endoscopies. Outcome was measured using video comparison and a staging system that includes histological assessment. Duodenal cancer developed in one patient, and was suspected in two others. The stage of duodenal polyposis worsened in another seven patients. When histology was ignored, comparison of video recordings in 52 patients showed a worsening in 21 (40%). In conclusion, further surveillance appears warranted so that patients at high risk for duodenal cancer might receive early treatment. Should slow progression of duodenal polyposis be shown to be associated with low risk, then most patients can be safely offered less frequent endoscopies than hitherto.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (636K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, Hamilton SR. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992 Jun;102(6):1980–1982. [PubMed]
  • Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum. 1993 Nov;36(11):1059–1062. [PubMed]
  • Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg. 1993 Dec;80(12):1618–1619. [PubMed]
  • Spigelman AD, Williams CB, Phillips RK. Rectal polyposis as a guide to duodenal polyposis in familial adenomatous polyposis. J R Soc Med. 1992 Feb;85(2):77–79. [PMC free article] [PubMed]
  • Nugent KP, Spigelman AD, Williams CB, Phillips RK. Iatrogenic pancreatitis in familial adenomatous polyposis. Gut. 1993 Sep;34(9):1269–1270. [PMC free article] [PubMed]
  • Spigelman AD, Jensen W, Bulow S. Duodenal cancer in polyposis patients. Gastroenterology. 1992 Dec;103(6):1995–1995. [PubMed]
  • Iida M, Yao T, Itoh H, Watanabe H, Matsui T, Iwashita A, Fujishima M. Natural history of duodenal lesions in Japanese patients with familial adenomatosis coli (Gardner's syndrome). Gastroenterology. 1989 May;96(5 Pt 1):1301–1306. [PubMed]
  • Noda Y, Watanabe H, Iida M, Narisawa R, Kurosaki I, Iwafuchi M, Satoh M, Ajioka Y. Histologic follow-up of ampullary adenomas in patients with familial adenomatosis coli. Cancer. 1992 Oct 1;70(7):1847–1856. [PubMed]
  • Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992 Mar 5;326(10):658–662. [PubMed]
  • Penna C, Phillips RK, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg. 1993 Aug;80(8):1027–1029. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press